RichardsonMD. Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother.2005; 56(Suppl 1): i5–i11.
3.
FrickS, CernyA. Necrotizing fasciitis due to Streptococcus pneumoniae after intramuscular injection of nonsteroidal anti-inflammatory drugs: report of 2 cases and review of the literature. Clin Infect Dis.2001; 33: 740–744.
4.
WongCH, KhinLW. Clinical relevance of the LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score for assessment of necrotizing fasciitis. Crit Care Med.2005; 33: 1677.
5.
Auquier-DunantA, MockenhauptM, NaldiL, CorreiaO, SchröderW, RoujeauJC SCAR Study Group. Severe Cutaneous Adverse Reactions. Correlation between clinical patterns and causes of erythema multiforme major, Stevens-Johnson syndrome, and toxic epidermal necrolysis:results of an international prospective study. Arch Dermatol.2002; 138: 1019–1024.
6.
ChaveTA, MortimerNJ, SladdenMJ, HallAP, HutchinsonPE. Toxic epidermal necrolysis: current evidence, practical management and future directions. Br J Dermatol.2005; 153: 241–253.
HighWA, ArandaJ, PatelSB, CockerellCJ, CostnerMI. Is Degos, disease a clinical and histological end point rather than a specific disease?J Am Acad Dermatol.2004; 50: 895–899.
14.
BallE, NewburgerA, AckermanAB. Degos, disease: a distinctive pattern of disease, chiefly of lupus erythemato-sus, and not a specific disease per se. Am J Dermatopathol.2003; 25: 308–320.
